Annual shareholder meetings

Explore recordings and documents from the meetings

6 May 2025
Annual General Meeting

The next Annual General Meeting will take place on May 6, 2025 in Kaiseraugst, Switzerland.

7 May 2024
Annual General Meeting

The Annual General Meeting of DSM-Firmenich AG took place on 7 May 2024 at the company’s head offices at Wurmisberg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.

Annual General Meetings (EN) 

Annual General Meetings (DE) 

Annual General Meetings (NL) 

Annual General Meetings (FR) 

Voting results

Invitation to the Annual General Meeting

Voting instructions can be provided through this link.

AGM minutes

  Documents

Integrated Annual Report 2023

Sustainability Report 2023 (Extract from the Integrated Annual Report 2023)

Compensation Report 2023 (Extract from the Integrated Annual Report 2023)

 Supporting documents for
 meeting attendance/voting

Shareholder meeting user manual  

Shareholder meeting Q&As 

Policy on use of electronic means at Hybrid Meetings

The extraordinary general meeting of shareholders was held on June 29, 2023 at the company offices at Wurmisweg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.

The shareholders or shareholder representatives voted on 197,464,498 shares or 74.45% of the issued share capital entitled to vote. Number of votes per share is 1 and the number of outstanding shares on 29 June 2023, the date of the meeting, was 265,217,171.

 

EGM (EN)

EGM (DE)

EGM (NL)

EGM (FR)

Agenda item 1:

Approval of the stand-alone interim financial statements of DSM-Firmenich AG for the period from 1 January 2023 to 8 May 2023

 ForAgainstAbstain

Total

Votes

195,384,208

1,200,493

879,797

197,464,498

%

98.95%

0.61%

0.45%

 
Agenda item 2:

Dividend / Distribution of Capital Contribution Reserves

 ForAgainstAbstain

Total

Votes

197,445,780

8,293

10,425

197,464,498

%

99.99%

0.00%

0.01%

 
Agenda item 3.1

Approval of remuneration for the Board of Directors

 ForAgainstAbstain

Total

Votes

195,384,208

4,485,119

1,076,031

197,464,498

%

97.18%

2.27%

0.54%

 
Agenda item 3.2

Approval of the remuneration of the Executive Committee

 ForAgainstAbstain

Total

Votes

191,489,400

4,476,258

1,498,840

197,464,498

%

96.97%

2.27%

0.76%

 
Agenda item 4.1

Approval of certain important transactions by shareholders

 ForAgainstAbstain

Total

Votes

185,937,469

3,530,633

7,996,396

97,464,498

%

94.16%

1.79%

4.05%

 
Agenda item 4.2

Possibility of the Board of Directors to request custodians to disclose the identity of shareholders and beneficial owners

 ForAgainstAbstain

Total

Votes

184,157,906

3,790,079

9,516,513

197,464,498

%

93.26%

1.92%

4.82%

 
  Documents

Invitation to the extraordinary general meeting

Voting instructions can be provided through this link.

EGM presentation - 29 June 2023

EGM minutes

  Supporting documents
  Agenda item 1

Interim Financial Statements  

  Agenda item 3

Remuneration at dsm-firmenich

Statement on BoD and Exco remuneration (ENG) 

Statement on BoD and Exco remuneration (NL) 

  Agenda item 4

Articles of association (with proposed amendments highlighted)

Article of association (with proposed amendments)

  Hybrid meeting guidance

Policy on use of electronic means

Hybrid meeting shareholder manual

Hybrid meeting Q&A's

Contact

We would love to hear from you! If you have any questions, please contact us via e-mail button below.

Explore more
  • Corporate governance

    We are fully committed to good corporate governance. Our principles and rules on corporate governance are laid down in the articles of association and the organizational regulations, among other documents.

  • Sustainability

    Sustainability is fundamental to how dsm-firmenich brings progress to life – for people and planet.

  • Investors

    Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.